Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 22 studies | 30% ± 15% | |
connective tissue cell | 7 studies | 33% ± 14% | |
myofibroblast cell | 6 studies | 35% ± 12% | |
mesothelial cell | 5 studies | 42% ± 16% | |
smooth muscle cell | 4 studies | 28% ± 10% | |
adventitial cell | 3 studies | 17% ± 0% | |
plasmacytoid dendritic cell | 3 studies | 24% ± 9% |
Insufficient scRNA-seq data for expression of MMP23B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 349.50 | 180 / 180 | 73% | 2.85 | 312 / 430 |
lung | 100% | 150.31 | 576 / 578 | 10% | 0.27 | 117 / 1155 |
stomach | 84% | 36.48 | 300 / 359 | 26% | 0.64 | 74 / 286 |
esophagus | 78% | 46.27 | 1128 / 1445 | 28% | 0.54 | 51 / 183 |
bladder | 100% | 131.10 | 21 / 21 | 6% | 0.08 | 28 / 504 |
uterus | 94% | 131.24 | 160 / 170 | 10% | 0.19 | 48 / 459 |
intestine | 89% | 45.37 | 860 / 966 | 10% | 0.23 | 53 / 527 |
prostate | 97% | 144.03 | 237 / 245 | 2% | 0.02 | 9 / 502 |
heart | 98% | 90.84 | 842 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 148.40 | 1229 / 1335 | 0% | 0 | 0 / 0 |
spleen | 83% | 32.77 | 201 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 80% | 27.46 | 206 / 258 | 3% | 0.05 | 6 / 230 |
breast | 79% | 44.39 | 362 / 459 | 2% | 0.03 | 24 / 1118 |
kidney | 79% | 34.70 | 70 / 89 | 1% | 0.02 | 7 / 901 |
thymus | 76% | 30.54 | 497 / 653 | 1% | 0.03 | 9 / 605 |
adipose | 77% | 51.69 | 922 / 1204 | 0% | 0 | 0 / 0 |
liver | 62% | 18.24 | 139 / 226 | 1% | 0.02 | 5 / 406 |
skin | 45% | 18.52 | 818 / 1809 | 1% | 0.01 | 3 / 472 |
peripheral blood | 42% | 25.04 | 394 / 929 | 0% | 0 | 0 / 0 |
pancreas | 24% | 6.21 | 78 / 328 | 15% | 0.25 | 27 / 178 |
brain | 33% | 7.48 | 874 / 2642 | 2% | 0.05 | 17 / 705 |
muscle | 5% | 0.95 | 42 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0030574 | Biological process | collagen catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008237 | Molecular function | metallopeptidase activity |
Gene name | MMP23B |
Protein name | Matrix metallopeptidase 23B MIFR-2 (Matrix metallopeptidase 23B) Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (Femalysin) (MIFR-1) (Matrix metalloproteinase-21) (MMP-21) (Matrix metalloproteinase-22) (MMP-22) [Cleaved into: Matrix metalloproteinase-23, soluble form] |
Synonyms | MMP22 MMP21 mifr-2 |
Description | FUNCTION: Protease. May regulate the surface expression of some potassium channels by retaining them in the endoplasmic reticulum (By similarity). . |
Accessions | B4DMZ6 H0Y6I4 O75086 H0YA69 J3KRS4 ENST00000435358.5 H0YAE5 ENST00000356026.10 [O75900-1] ENST00000512731.5 ENST00000503792.1 D6REP6 ENST00000472264.1 ENST00000490017.1 O75900 ENST00000378675.7 ENST00000479814.5 |